Weimai

About Weimai

Weimai is a digital health company founded in September 2015 by Jialin Qiu, who has an extensive background in medical intelligence systems. The company operates a city-level internet health and medical data platform in China, aiming to digitize and upgrade healthcare services.

The platform connects public hospitals, medical staff, and patients to provide comprehensive, full-cycle healthcare management. Its services cover the entire patient journey, from pre-treatment processes like appointments and online consultations to post-treatment care, including rehabilitation, health monitoring, and follow-ups. Weimai has developed a proprietary AI, named CareAI, which assists in creating personalized health management plans, analyzing patient data, and providing health recommendations in various formats. This technology enables the company to manage over 1,000 diseases and has significantly increased the efficiency of case managers.

The business model is centered on a Chinese Managed Care Organization (C-MCO) approach, focusing on providing continuous health services beyond single hospital visits. Revenue is primarily generated from patients purchasing these full-cycle management services, which account for about 70% of the company's income. Other revenue streams include the sale of healthcare products and insurance brokerage services. The company partners with public hospitals, establishing dedicated management centers within them to deliver its services. As of late 2024, Weimai had partnered with over 157 hospitals for deep collaboration and over 4,700 institutions for other services, serving approximately 500,000 patients in its full-cycle programs. The company filed for an IPO on the Hong Kong Stock Exchange in June 2025.